CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 33 enrolled
Drug / intervention
Diphenhydramine Hydrochloride +1 moredrug
Likely dose
Diphenhydramine Hydrochloride 30 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02578186
NCT02578186Phase 4Completed
CompareCT.gov

Randomized, Double-Blind, Placebo-Controlled, Crossover, In-home Study to Assess the Efficacy of Diphenhydramine Hydrochloride in Subjects With Occasional Sleeplessness

Procter and Gamble·interventional·Posted Oct 16, 2015·Updated Mar 15, 2017

In Brief

A Phase 4 clinical trial evaluating Diphenhydramine Hydrochloride and Placebo for Occasional Sleeplessness. Completed, enrolled 33 participants.

Detailed Summary

The present study was conducted to investigate the impact of diphenhydramine hydrochloride on the ability to initiate sleep.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOccasional Sleeplessness
Countries--
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 16, 2015
Enrollment StartNov 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.7 years ago

Interventions

Diphenhydramine Hydrochloridedrug

30 mL at bedtime

Placebodrug

30 mL at bedtime